Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Second‐generation antipsychotic drugs for major depressive disorder

Esta versión no es la más reciente

ver la versión actual 08 diciembre 2010

Información

DOI:
https://doi.org/10.1002/14651858.CD008121Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 octubre 2009see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Trastornos mentales comunes

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Katja Komossa

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Anna M Depping

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Werner Kissling

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Stefan Leucht

    Correspondencia a: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

    [email protected]

Contributions of authors

Katja Komossa: protocol development.

Stefan Leucht: protocol development.

Werner Kissling: protocol development.

Anna Mareike Depping: protocol development.

Sources of support

Internal sources

  • Freistaat Bayern, Germany.

External sources

  • Bundesministerium für Bildung und Forschung, Germany.

Declarations of interest

Katja Komossa: none to declare.

Stefan Leucht: received speaker/consultancy/advisory board honoraria from SanofiAventis, BMS, EliLilly, Janssen/Johnson and Johnson, Lundbeck and Pfizer. SanofiAventis and EliLilly supported research projects by Stefan Leucht.

Werner Kissling: received speaker or consultancy honoraria from SanofiAventis, BMS, Lilly, Janssen, Lundbeck, Bayer and Pfizer.

Anna Mareike Depping: none to declare.

Acknowledgements

We would like to thank all members of the Cochrane Depression, Anxiety and Neurosis editorial team for their editorial assistance.

Version history

Published

Title

Stage

Authors

Version

2010 Dec 08

Second‐generation antipsychotics for major depressive disorder and dysthymia

Review

Katja Komossa, Anna M Depping, Andrea Gaudchau, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD008121.pub2

2009 Oct 07

Second‐generation antipsychotic drugs for major depressive disorder

Protocol

Katja Komossa, Anna M Depping, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD008121

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;